Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | RORC | P51449 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.33 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 7/20 | 0.32 |
| ▸ | ABHD6 | Q9BV23 | 1/20 | 0.32 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.32 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
| ▸ | JAK2 | O60674 | 1/20 | 0.32 |
| ▸ | JAK3 | P52333 | 1/20 | 0.32 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.30 |
| ▸ | IGF1R | P08069 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15628442 | 0.95 | ALDH1A1 (0.46) | ALDH1A1RORCKDM4ETGFBR1ACVR1 | |
| SCHEMBL15628607 | 0.86 | ALDH1A1 (0.38) | ALDH1A1KDM4EHIF1AIGF1R | |
| SCHEMBL15628457 | 0.85 | ALDH1A1 (0.40) | ALDH1A1KDM4EHIF1A | |
| SCHEMBL20026122 | 0.81 | CA1 (0.41) | — | |
| SCHEMBL13527698 | 0.81 | ALDH1A1 (0.38) | ALDH1A1RORCKDM4ETGFBR1ACVR1 | |
| SCHEMBL14023911 | 0.79 | ALDH1A1 (0.41) | ALDH1A1RORCKDM4EHIF1A | |
| SCHEMBL19062581 | 0.79 | ALDH1A1 (0.41) | ALDH1A1RORCKDM4EHIF1A | |
| SCHEMBL15628603 | 0.78 | ADRB1 (0.48) | ALDH1A1KDM4ETGFBR1 | |
| SCHEMBL14025102 | 0.76 | KDM4E (0.47) | ALDH1A1RORCKDM4EFAAHABHD6 | |
| SCHEMBL13527625 | 0.75 | ALDH1A1 (0.41) | ALDH1A1RORCKDM4ETGFBR1ACVR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180094016-A1 | Triazole Compounds And Methods Of Making And Using The Same | BioVersys AG (CH) | 2018-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180094016-A1 | Triazole Compounds And Methods Of Making And Using The Same | IL33, PROKR1, VIP | ALDH1A1 3532/4885RORC 316/4885KDM4E 4532/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.